BridgeBio Oncology Therapeutics, Inc. Common Stock
$3.95
▼ 0.04
(-1.00%)
Volume: 523,528
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
13
- 21d momentum -57.3%
- MA aligned bearish
- RSI 15 oversold
🎯
Pullback
81
- RSI 15 near lows
- Near lower Bollinger band
- -36.8% vs 20MA
💎
Value
58
- -73% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)15.5
MACD-0.183
MA trendBearish
ATR11.99%
21d mom.-57.3%
63d mom.-46.6%
vs 20MA-36.8%
RVOL(20)0.75×
52w low · 4
52w high · 15
-73.4% from 52-week high
20d support 4
· resistance 9
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$320M
PER—
PBR0.99
PSR—
EPS$-2.27
ROE-56.4%
ROA-48.3%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-1.34
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -17.19% | -57.34% | -46.62% | -57.20% | -65.29% | -67.86% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -56.01%, daily vol 6.16%. BridgeBio Oncology Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.